New Market Research Report: India Infectious Diagnostics Market Outlook to 2021

From: Fast Market Research, Inc.
Published: Tue Dec 08 2015


GlobalData's new report, "India Infectious Diagnostics Market Outlook to 2021", provides key market data on the India Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Report Scope

Full Report Details at
- http://www.fastmr.com/prod/1081624_india_infectious_diagnostics.aspx?afid=301

* Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
* Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
* 2014 company shares and distribution shares data for Infectious Diagnostics market.
* Global corporate-level profiles of key companies operating within the India Infectious Diagnostics market.
* Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to Get this Report

* Develop business strategies by identifying the key market segments poised for strong growth in the future.
* Develop market-entry and market expansion strategies.
* Design competition strategies by identifying who-stands-where in the market.
* Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
* What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned in this Report: Transasia Bio-Medicals Ltd., Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, bioMerieux S.A., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Hologic, Inc., Alere Inc., Tulip Diagnostics (P) Ltd, Span Diagnostics Ltd.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Canada In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
- United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
- Canada Infectious Diagnostics Market Outlook to 2021
- France Infectious Diagnostics Market Outlook to 2021
- United Kingdom Infectious Diagnostics Market Outlook to 2021

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »